Jeremy Snyder
banner
jsnyder.bsky.social
Jeremy Snyder
@jsnyder.bsky.social
Professor in the Faculty of Health Sciences at Simon Fraser University in British Columbia, Canada. Interested in public health ethics, bioethics, philosophy, crowdfunding, and exploitation, among other things.
Pinned
The bioethics/applied health ethics/public health ethics starter pack is full (150 people!). Rather than removing less active folks or gatekeeping I'll start another one - so keep letting me know if you're interested in being listed or see anyone who should be added. go.bsky.app/ERXDCeB
I just set up a starter pack for bioethics/applied health ethics/public health ethics. I'm sure I've missed a ton of people, so let me know if you'd like to be included.

go.bsky.app/HQVYom8
Reposted by Jeremy Snyder
I would also like to see this, which was reported by the WSJ www.wsj.com/world/europe...
September 16, 2026 at 4:36 PM
Reposted by Jeremy Snyder
🚩 Ivermectin = MAJOR RED FLAG FOR BUNK 🚩

Watchdog asked Amazon to remove listings for dozens of medicines, many of which included Ivermectin www.irishtimes.com/health/2026/...

"...promoted online as a cure or treatment for a wide variety of health conditions including cancer and autism."
Watchdog asked Amazon to remove listings for dozens of medicines, many of which included Ivermectin
HPRA wrote to the online retailer asking for a permanent block to be placed on products
www.irishtimes.com
September 15, 2026 at 3:34 PM
Reposted by Jeremy Snyder
Accepting proposals for book reviews for the Canadian Journal of Disability Studies. Send me an email with your book, or idea for a review of a book. I'm open to reviews of art and film as well. So get creative and send me a note.
September 12, 2026 at 5:25 PM
@leighturner.bsky.social & I show how problematic journal articles can keep shambling along after retraction. These zombie articles continue to appear without notice of their status on publishers' websites, other publications, promotional materials, and, now, AI search results.
Why retracted articles can have an influential afterlife—and what to do about it
Abstract. Retractions of published journal articles are an increasingly common means by which the research community ensures the quality and integrity of p
academic.oup.com
September 10, 2026 at 5:38 PM
I'm very happy to share a new OA publication in Public Health Ethics. I argue for the inclusion of a principle of non-complicity among other public health ethics principles & that non-complicity complements other ethical principles & particularly addresses limitations in a principle of solidarity.
Non-complicity as a principle of public health ethics
Abstract. The concept of complicity has received increased interest in academic and popular venues to describe a range of moral phenomena including contrib
academic.oup.com
September 10, 2026 at 4:36 PM
Reposted by Jeremy Snyder
Faculty position at Calgary

careers.ucalgary.ca/jobs/1820090...
September 4, 2026 at 1:38 AM
Reposted by Jeremy Snyder
🚨Update: Our analysis of global APC expenditure has now been expanded to cover more publishers (7 -> 14) and more years (2019-2025).

We estimate $15B in APCs paid over seven years, $3.7B in 2025 alone. Elsevier crosses the $1B threshold by itself in 2025.

arxiv.org/abs/2608.16322 #ScholComm
August 31, 2026 at 1:16 PM
Reposted by Jeremy Snyder
This is heartbreaking. “Presten had chronic myeloid leukemia, but he had not been seen by the hospital’s oncology team in more than a year. Mooney had been caring for him at home, using alternative treatments guided by an unlicensed practitioner. She didn’t trust the hospital to help her son”
Why MAHA Rallied for a Mother Seeking Alternative Treatments for Her Son’s Cancer
Dayna Mooney chose alternative remedies over the recommendations of her son’s doctors. Was that her right as a parent or a threat to his care?
www.nytimes.com
September 1, 2026 at 4:34 PM
Reposted by Jeremy Snyder
Very happy that philosopher Talia Mae Bettcher has been appointed as an Eddie Goldenberg Research Chair of Canada @ Waterloo, with long term funding to lead ambitious research programs aligned with Canada’s strategic priorities.

#philosophy

uwaterloo.ca/news/waterlo...
Waterloo welcomes inaugural Eddie Goldenberg Research Chairs | Waterloo News | University of Waterloo
Global research leaders choose Waterloo to advance transformative research that supports Canada’s strategic priorities and future prosperity
uwaterloo.ca
August 27, 2026 at 7:08 PM
Reposted by Jeremy Snyder
International student visa applications and approvals, Canada 2022-2025. We're down 90% on where we were three years ago. Given that intl student fees brought in about $14B at their peak, we're looking at the potential loss by 2028 of $12B of PSE income (or about 16% of the total).
August 26, 2026 at 12:57 AM
Reposted by Jeremy Snyder
If you haven’t already, I encourage you to check out The Society for Nursing Ethics International (SONEI). The SONEI website includes a rich repository of nursing-ethics related resources. My essay on everyday ethics in nursing is on the SONEI blog this week:
Ethical awareness in everyday nursing practice
Aimee Milliken PhD, RN, HEC-C When you think about ethics, what comes to mind? You may imagine famous cases you learned about in school, like Karen Ann Quinlan, Nancy Cruzan, or Terri Schaivo.…
sonei.org
August 25, 2026 at 7:49 PM
Reposted by Jeremy Snyder
2025-26: the first year Canadian universities employed more tenured/TT professors over the age of 70 than under the age of 35.
August 25, 2026 at 1:20 AM
Lots of British Columbians would love to see some US nurses and family physicians heading up here.
Watch Dr. Kopstick's story and hear why he chose to build his future in BC.

Know a health-care worker in the US? Share this story, or tag them in the comments, and let them know BC's hiring.
August 25, 2026 at 12:22 AM
Interesting interview with @gofundme.com CEO Tim Cadogan and @reckless.bsky.social. Cadogan says an advantage of private donations over the public safety net is that donations come "with love". This ignores consistent findings that this 'love' is distributed very, very inequitably.
August 24, 2026 at 6:31 PM
Reposted by Jeremy Snyder
Our new piece in BMJ: Artificial intelligence as a new commercial determinant of health www.bmj.com/content/bmj/...
August 9, 2026 at 2:46 PM
A detailed write up of the link between Harp, Right to Try, and the Trump administration from @benstockton.bsky.social in the Telegraph with some quotes and analysis from me.
August 20, 2026 at 1:35 PM
Natalie Harp and Right to Try (RTT) thread! Natalie Harp is in the news this week. I became very familiar with her story six years ago in writing a piece for the Washington Post that focused on Trump’s federal RTT legislation aimed at providing access to unapproved medical interventions. /1
Perspective | Trump brags that he’s helping patients access medical ‘miracles.’ He isn’t.
Evidence that ‘Right to Try’ has improved patients’ lives is basically non-existent.
www.washingtonpost.com
August 19, 2026 at 6:58 PM
Wow - wildly unethical at the very least: “Median Strategies was created as a short-term social experiment examining how purported polling information could enter and spread through the political information ecosystem without independent verification.”

"Purported" here seems to equal "fake".
Josh Marshall on a completely unethical “experiment.” Also a reminder never to let polls affect your enthusiasm and organizing.
From The Annals of Polling, Part 1
Today I’m going to discuss two tidbits from the world of polling....
talkingpointsmemo.com
August 18, 2026 at 9:26 PM
Reposted by Jeremy Snyder
Learn to Ode!
August 17, 2026 at 3:17 PM
CIHR, Canada's health granting agency, reports a flat number of grants funded with applications up over 50% in 5 years. "The result is more time spent preparing, administering and reviewing applications with ever-lower likelihoods of funding success"
What we heard: Strengthening the long-term sustainability of the Project Grant program - CIHR
The purpose of this phase of our engagement has not been to make or announce decisions. It has been to build a shared understanding of the pressures facing the system and to hear from applicants, reviewers and institutions on possible interventions and their implications.
cihr-irsc.gc.ca
August 6, 2026 at 2:52 PM
Reposted by Jeremy Snyder
This is very good article in the Beijing News on the gene therapy trial death of a girl, a story broken in Borrell's stunning piece in Science. (At least it looks good in my laborious Google Translate version, despite quoting me)

www.bjnews.com.cn/detail/17858...

www.science.org/content/arti...
6岁女童夭折背后,一场失败的“全球首例”脑部基因编辑试验 — 新京报
新京报以文字、图片、视频等全媒体形式,为用户提供全天候热点新闻,涵盖突发新闻、时事、财经、娱乐、体育,以及评论、杂志和博客等,新京报网本着品质源于责任的的信念,致力于成为用户喜爱的精品新闻网站。
www.bjnews.com.cn
August 5, 2026 at 5:40 PM
Reposted by Jeremy Snyder
RFKJr continues to stack FDA advisory panels with charlatans and snake oil salesmen. RFK Jr. adds 8 members to a 6 member FDA advisory panel. 6 of them were sellers of peptides, and the 7th a compounding pharmacist.
FDA Panel Supports Lifting Restrictions on Four Peptides
In an all-day hearing, the agency’s scientists argued against allowing broad access to unproven drugs that the agency had banned three years ago.
www.nytimes.com
July 24, 2026 at 1:44 PM
Reposted by Jeremy Snyder
How is AI changing the ways commercial actors influence health?

Check out our new article published in BMJ: "Artificial intelligence as a new commercial determinant of health."

We introduce the AI commercial determinants of health (AI-CDoH) framework 🧵 @bmj.com 1/9
July 22, 2026 at 8:34 AM
Reposted by Jeremy Snyder
Yet another Kalshi offering that serves no legitimate economic purpose. It's not possible to make a rational bet on this without material non-public information. It's a market solely for fraud by both regulators and corporate insiders, and everyone connected to it in any way should go to prison.
Kalshi Will Offer Sports-Style Betting on Drug Trial Results
Kalshi Inc. is expanding in biotechnology by offering wagers on the outcomes of clinical trials and regulatory decisions, giving traders a more direct way to bet on key industry catalysts.
www.bloomberg.com
July 16, 2026 at 1:38 PM